Full papers list：
2026年：
1. Fanchun Hu#, Yuhan Ding#, Caiting Deng, Jingjing Zhang, Wei Qu, Yanqin Rong, Nandi Chen*, Mengjiao Zhou*, Feifei An*, SO2 gas potentiator engineered for self-amplifying chemo-radiotherapy in breast tumors, Chinese Chemical Letters. 2026, 112277. (IF=8.9)
2. Jingjing Zhang, Jiayao Zhao, Huihui Lu, Haluk B. Sayman, Feifei An*, Richard Ting*, Wei Qu*, Turn-on near-infrared fluorescence/positron emission tomography dual-modal probe for intracranial hemorrhage diagnosis, J. Mater. Chem. B, 2026,14, 916-926.
3. Jingjing Zhang, Fanchun Hu, Caiting Deng, Yuhan Ding, Yuchen Yang, Shupeng Han, Jun Liu, Feifei An*, Mingsong Shi*, A prostate-specific membrane antigen targeted small molecule-drug conjugate for efficient prostate cancer therapy at a low dosage, International Journal of Pharmaceutics: X, 2026, 11, 100496.
4. Jiayao Zhao, Jingjing Zhang, Huihui Lu, Yanan Li*, Feifei An*, Yichao Chai*, Tumor Microenvironment-Activatable NIR-II Fluorescent Probes: Design Strategies and Therapeutic Applications, Journal of Drug Delivery Science and Technology, 2026, 120, 108274.
5. Hongyu Chen, Lu Li, Zechao Zhu, Jiagen Li, Jing Tu, Hui Liu, Guowei Deng*, Feifei An*, Jun Liu*, A biodegradable D-π-A structured hemicyanine for constructing tumor-targeted nanoplatform by Cu-64 PET/NIR-II fluorescent/photoacoustic imaging-guided photodynamic and photothermal therapy, Chinese Chemical Letters, 2026, 112400.
6. Ming Zhou#, Xiaoqin Yin#, Yi Yang, Jian Li, Peng Liu, Jinhui Yang, Pengfei Xu*, Shuo Hu*, Feifei An*, An Evans Blue-Modified Melanin-Targeting Theranostic Agent for Improved PET Imaging and Radionuclide Therapy of Malignant Melanoma. Chinese Chemical Letters, 2026, 112361. (IF = 8.9)
2025年：
7. Caiting Deng, Jingjing Zhang, Yuchen Yang, Yuhan Ding, Feifei An*, Fu Wang*, Chemodynamic Therapy Enhanced 131I-Radiotherapy for Efficient Inhibition on Cancer Growth and Metastasis. Small. 2025, 21(27)2503117. (IF = 12.1).
8. Yuhan Ding, Yuchen Yang, Omer Aras, Feifei An*, Mengjiao Zhou *, Yichao Chai*, Development and application of organic sonosensitizers in cancer therapy, Aggregate 2025, 6 (6), e70032. (IF = 13.7) Inside Front Cover
9. Yuhan Ding, Caiting Deng, Yuchen Yang, Jingjing Zhang, Wen Liu, Omer Aras, Feifei An*, Jun Liu*, Yichao Chai*, Carrier-free nanoparticles for cancer theranostics with dual-mode magnetic resonance imaging/fluorescence imaging and combination photothermal and chemodynamic therapy. International Journal of Pharmaceutics. 2025, 671, 125285 (IF = 5.30). ESI高被引
10. Shupeng Han, Caiting Deng, Meichen Zheng, Linwei Yang, Hancun Kong, Yongchao He, Yinuo Zheng, Guowei Deng, Yu Ren*, Feifei An*, A GSH-responsive NIR-BODIPY fluorophore with large Stokes-shift for tumor specific fluorescence imaging and surgical guidance. Chinese Chemical Letters. 2025, 36(7)110459. (IF=8.9)
2024年：
11. Caiting Deng, Jingjing Zhang, Fanchun Hu, Shupeng Han, Meichen Zheng, Feifei An*, Fu Wang*, A GSH-responsive Prodrug with Simultaneous Triple-activation Capacity for Photodynamic/Sonodynamic Combination Therapy with Inhibited Skin Phototoxicity. Small, 2024, 20(40) 2400667 (IF = 12.1)
12. Yi Liu, Xiaoning Wang, Hui Feng, Xinyan Li, Runyu Yang, Mengyao Zhang, Yue Du, Ruimin Liu, Minna Luo, Zhiyi Li, Bo Liu, Jincheng Wang, Wenjuan Wang, Feifei An*, Fan Niu*, Pengcheng He*, Glutathione-depleting liposome adjuvant for augmenting the efficacy of a Glutathione covalent inhibitor oridonin for acute myeloid leukemia therapy, Journal of Nanobiotechnology. 2024, 22 (1), 299 (IF = 12.6).
13. J Xin, S Han, M Zheng, C Xu, Z Huang, B Wang, C Yu, F An*, Y Ren*, A nitroreductase-responsive nanoprobe with homogeneous composition and high loading for preoperative non-invasive tumor imaging and intraoperative guidance, Chinese Chemical Letters. 2024, 35(7)109165. (IF = 8.9)
14. Meichen Zheng, Jingjing Zhang, Caiting Deng, Lei Chen, Heng Zhang, Jingqi Xin, Omer Aras, Mengjiao Zhou*, Feifei An*, Yu Ren*, The collaborated assembly of hydrophobic curcumin and hydrophilic cyanine dye into nanocolloid for synergistic chemo-photothermal cancer therapy, Materials & Design, 2024, 241, 112900. (IF = 7.9)
15. M Zheng, T Mei, C Deng, J Xin, O Aras, F An*, N Chen*, The Influence of PEG Chain Length on the in vivo Tumor Accumulation of Self-assembled Amphiphilic Drug-PEG Polymeric Micelles, Colloids and Surfaces A: Physicochemical and Engineering Aspects, 2024, 682,132823. (IF = 5.4)
16. Jingjing Zhang, Fanchun Hu, Omer Aras, Yichao Chai*, Feifei An*, Small Molecule-Drug Conjugates: Opportunities for The Development of Targeted Anticancer Drugs, ChemMedChem, 2024, 19(11)e202300720. (IF = 3.4)
2023年：
17. Caiting Deng, Meichen Zheng, Shupeng Han, Yuanjie Wang, Jingqi Xin, Omer Aras, Liang Cheng*, Feifei An*, GSH-activated Porphyrin Sonosensitizer Prodrug for Fluorescence Imaging-guided Cancer Sonodynamic Therapy, Advanced Functional Materials. 2023, 33(32)2300348. (IF = 18.5)
18. Caiting Deng, Meichen Zheng, Jingqi Xin, Feifei An*, A nanoparticle composed of totally hospital-available drugs and isotope for fluorescence/SPECT dual-modal imaging-guided photothermal therapy to inhibit tumor metastasis, Journal of Colloid and Interface Science. 2023, 651, 384-393. (IF = 9.4)
19. M Zhou, P Liu, X Yin, C Deng, Y Xiao, M Lei, S Hu, F An*, M Zhao*, A SPECT/NIR Fluorescence Dual-Modality Imaging Agent Composed of Drugs and Hospital Available Isotope for Preoperative Sentinel Lymph Node Mapping and Intraoperative Biopsy, International Journal of Nanomedicine, 2023,18,7637-7646. (IF = 6.7)
20. J Xin, C Deng, M Zheng, F An*, Amphiphilic photosensitizer polymer as a nanocarrier of cytotoxic molecule for carrier-free combination therapy, MedComm–Biomaterials and Applications 2023, 2 (1), e28
21. L Zhu, M Luo, Y Zhang, F Fang, M Li, F An, D Zhao, J Zhang. Free radical as a double-edged sword in disease: Deriving strategic opportunities for nanotherapeutics. Coordination Chemistry Reviews 2023, 475, 214875
22. L Xie, X Ying, X Li, X Tan, T Zhang, X Zhang, W Cai, F An, X Liu, S Han. Engineering of gold nanorods as multifunctional theranostic agent for photothermal-enhanced radiotherapy of cancer. Materials & Design 2023, 225, 111456.
23. Y Li, J Cui, C Li, C Deng, G Deng, H Zhang*, F An*, Biomaterial-assisted photoimmunotherapy for synergistic suppression of cancer progression. Chinese Chemical Letters, 2023, 34(9),108180
2022年：
24. Y Li, J Cui, C Li, H Zhou, J Chang, O Aras*, F An*. 19F MRI Nanotheranostics for Cancer Management: Progress and Prospects. ChemMedChem, 2022, 17 (4), e202100701
25. HB Sayman, F Gulsen, S Sager, E Akgun, N Yeyin, S Bilgic, KN Toplutas, Feifei An, Fatih Beytur, Rahmi Oklu, Omer Aras. Selective Intra-Arterial 177Lu-PSMA Therapy for Castration Resistant Prostate Cancer: Initial Results, Journal of vascular and interventional radiology: JVIR, 2022,33 (3), 342-345.
2021年：
26. M Zhou, M Yuan, M Zhang, C Lei, O Aras, X Zhang, F An*, Combining histone deacetylase inhibitors (HDACis) with other therapies for cancer therapy, European Journal of Medicinal Chemistry, 2021, 226,113825.
27. W Lin, Y Yang, Y Lei, F An, L Sun, Y Qin, L Zhang, Self-Assembly of an Antitumor Dipeptide Induced Near-Infrared Fluorescence and Improved Stability for Theranostic Applications, ACS Applied Materials & Interfaces 2021, 13 (28), 32799-32809
28. F An, J Xin, C Deng, X Tan, O Aras, N Chen, X Zhang, R Ting, Facile synthesis of near-infrared bodipy by donor engineering for in vivo tumor targeted dual-modal imaging, Journal of Materials Chemistry B, 2021,9(45) 9308-9315.
29. Y Li, C Zhang, G Li, G Deng, H Zhang*, Y Sun*, F An*, Protease-triggered bioresponsive drug delivery for the targeted theranostics of malignancy, Acta Pharmaceutica Sinica B, 2021, 11(8) 2220-2242.
30. Mengjiao Zhou, Shupeng Han, Omer Aras, Feifei An*. “Recent Advances in Paclitaxel-based Self-Delivery Nanomedicine for Cancer Therapy”, Current Medicinal Chemistry 2021;28(31):6358-6374.
31. Jingqi Xin, Caiting Deng, Omer Aras, Mengjiao Zhou*, Chunsheng Wu* and Feifei An*, Chemodynamic nanomaterials for cancer theranostics, Journal of Nanobiotechnology, 2021, 19, 192.
2020年：
32. FF An, F Nurili, H Sayman, Z Ozer, H Cakiroglu, O Aras, R Ting, One-step, Rapid, 18F-19F Isotopic Exchange Radiolabeling of Difluoro-dioxaborinins: Substituent Effect on Stability and In Vivo Applications, Journal of Medicinal Chemistry, 2020, 63, 21, 12693-12706.
33. Yanan Li, Jingqi Xin, Yongbing Sun, Tao Han, Hui Zhang, Feifei An*, “Magnetic resonance imaging-guided and targeted theranostics of colorectal cancer”, Cancer Biology & Medicine, 2020, 17(2), 307-327.
34. Yanan Li, Ting Mei, Shupeng Han, Tao Han, Yongbing Sun, Hui Zhang, Feifei An*, “Cathepsin B-responsive nanodrug delivery systems for precise diagnosis and targeted therapy of malignant tumors”, Chinese Chemical Letters, 2020, 31(12), 3027-3040.
35. N Chen, H Kommidi, H Guo, A P Wu, Z Zhang, X Yang, L Xia*, F An*, R Ting*, “A lysosome specific, acidic-pH activated, near-infrared Bodipy fluorescent probe for noninvasive, long-term, in vivo tumor imaging”, Materials Science and Engineering: C, 2020, 111, 110762.
36. F An, N Chen, W J Conlon, J S Hachey, J Xin, O Aras, E A Rodriguez, R Ting, “Small ultra-red fluorescent protein nanoparticles as exogenous probes for noninvasive tumor imaging in vivo”, International Journal of Biological Macromolecules, 2020, 153, 100-106.
37. F An, Z Yang, M Zheng, T Mei, G Deng, P Guo, Y Li, R Sheng, “Rationally assembled albumin/indocyanine green nanocomplex for enhanced tumor imaging to guide photothermal therapy”, Journal of Nanobiotechnology, 2020, 18, 49.
38. Y Tian, M Lei, L Yan and F An, “Diselenide-crosslinked zwitterionic nanogels with dual redox-labile properties for controlled drug release”. Polymer Chemistry, 2020, 11, 2360-2369
39. M Zhou, Y Xie, S Xu, J Xin, J Wang, T Han, R Ting, J Zhang*, F An*, “Hypoxia-activated nanomedicines for effective cancer therapy”. European Journal of Medicinal Chemistry, 2020, 195, 112274.
40. Y Li, Q Dong, T Mei, M Zheng, RR Kumar, B Yu, C Wu, H Zhang, F An*, “Nanosized Modification Strategies for Improving the Antitumor Efficacy of MEK Inhibitors”. Current Drug Targets, 2020, 21, 3, 228-251.
2019年：
41. YF Xiao, FF An*, JX Chen, J Yu, WW Tao, Z Yu, R Ting, CS Lee, XH Zhang, “The Nanoassembly of an Intrinsically Cytotoxic Near-Infrared Dye for Multifunctionally Synergistic Theranostics”. Small 2019, 15(38),1903121.
42. Y Li, L Du, C Wu, B Yu, H Zhang, F An*, “Peptide Sequence-Dominated Enzyme-Responsive Nanoplatform for Anticancer Drug Delivery” Current Topics in Medicinal Chemistry 2019, 19 (1), 74-97.
Before Joining XJTU：
43. Y Li, Y Chang, X Lian, L Zhou, Z Yu, H Wang, F An*. “Silver Nanoparticles for Enhanced Cancer Theranostics: In Vitro and In Vivo Perspectives” J. Biomed. Nanotechnol. 2018, 14 (9), 1515-1542.
44. Y Xiao, FF An*, J Chen, S Xiong, X Zhang. “The impact of light irradiation timing on the efficacy of nanoformula-based photo/chemo combination therapy” J. Mater. Chem. B 2018, 6 (22), 3692-3702.
45. N Chen, T Su, Z Cheng*, and FF An*. “Soft Biomaterial-based nanocrystal in Pharmaceutical”. Curr. Pharm. Des. 2018, 24 (21), 2349-2361
46. Y Wang, J Zhong, J Bai, R Tonga, F An, P Jiao, L He, D Zeng, E Long, et al. “The Application of Natural Products in Cancer Therapy by Targeting Apoptosis Pathways” Current Drug Metabolism 2018, 19 (9), 739-749
47. FF An, H Kommidi, N Chen, R Ting. “A conjugate of heptacyanine and 18F as a positron emission tomography/near-infrared fluorescence probe for multimodality tumor imaging” Int. J. Mol. Sci. 2017,18(6), 1214
48. FF An, XH Zhang. “Strategies for Preparing Albumin-based Nanoparticles for Multifunctional Bioimaging and Drug Delivery” Theranostics 2017, 7 (15), 3667-3689 (ESI高被引)
49. Y Wang, FF An (co-first author), M Chan, B Friedman, E A Rodriguez, R Y Tsien, O Aras, R Ting. “18F-positron-emitting/fluorescent labeled erythrocytes allow imaging of internal hemorrhage in a murine intracranial hemorrhage model” J Cereb Blood Flow Metab 2017, 37 (3), 776-786
50. FF An, M Chan, H Kommidi, R Ting. “Dual PET and Near-Infrared Fluorescence Imaging Probes as Tools for Imaging in Oncology” American Journal of Roentgenology 2016, 207: 266-273.
51. FF An, X Shi. “Stimulus-responsive Nanomedicine (editorial)”. Current Nanoscience 2016: 12 (1), 3-3
52. J Zhang, C Li, X Zhang, S Huo, S Jin, FF An*, X Wang, X Xue, CI Okeke, G Duan, F Guo, X Zhang, J Hao, P C Wang, J Zhang, XJ Liang. “In vivo tumor-targeted dual-modal fluorescence/CT imaging using a nanoprobe co-loaded with an aggregation-induced emission dye and gold nanoparticles”. Biomaterials, 2015, 42, 103-111.
53. JF Zhang, Y Li, FF An, X Zhang, XF Chen, CS Lee. “Preparation and Size Control of sub-100 nm Pure Nanodrugs”. Nano letters 2015, 15 (1), 313-318.
54. R Sheng, FF An, Z Wang, M Li, A Cao. “Assembly of Plasmid DNA with Pyrene-amines Cationic Amphiphiles into Nanoparticles and Their Visible Lysosome Localization”. RSC Advances 2015, 5, 12338-12345.
55. J Zhang, S Li, FF An, J Liu, S Jin, JC Zhang, PC Wang, X Zhang, CS Lee, “Self-carried curcumin nanoparticles for in vitro and in vivo cancer therapy with real-time monitoring of drug release”. Nanoscale 2015, 7 (32), 13503-13510.
56. FF An, ZJ Deng, J Ye, JF Zhang, YL Yang, CH Li, CJ Zheng, XH Zhang. “Aggregation-Induced Near-Infrared Absorption of Squaraine Dye in an Albumin Nanocomplex for Photoacoustic Tomography in Vivo” ACS Applied Materials & Interfaces 2014, 6 (20), 17985-17992.
57. FF An, W Cao, XJ Liang, “Nanostructural Systems Developed with Positive Charge Generation to Drug Delivery” Advanced healthcare materials 2014, 3 (8), 1162-1181.
58. FF An, YL Yang, J Liu, J Ye, JF Zhang, MJ Zhou, XJ Zhang, CJ Zheng, XJ Liang, XH Zhang. “A reticuloendothelial system-stealthy dye–albumin nanocomplex as a highly biocompatible and highly luminescent nanoprobe for targeted in vivo tumor imaging” RSC Advances 2014, 4 (12), 6120-6126.
59. FF An, Y Li, J Zhang. “Carrier-free photosensitizer nanocrystal for photodynamic therapy” Materials Letters 2014, 122, 323-326.
60. J Ye, K Wang, Z Chen, FF An, Y Yuan, C Zhang, XH Zhang, CS Lee. “Constructing a novel single-layer white organic light-emitting device through a new sky-blue fluorescent bipolar host” Organic Electronics 2014: 15 (12), 3514-3520.
61. J Ye, Z Chen, K Wang, F An, Y Yuan, W Chen, Q Yang, X Zhang, CS Lee. “A Bipolar Transporter as an Efficient Green Fluorescent Emitter and Host for Red Phosphors in Multi- and Single- Layer Organic Light Emitting Diodes.” Chemistry-A European Journal 2014: 20 (42), 13762-13769.
62. J Ye, Z Chen, F An, M Sun, HW Mo, XH Zhang, CS Lee. Achieving Highly Efficient Simple-Emission Layer Fluorescence/ Phosphorescence Hybrid White Organic Light-Emitting Devices via Effective Confinement of Triplets. ACS appl. Mater. interfaces 2014:6 (12), 8964-8970.
63. FF An, J Ye, JF Zhang, YL Yang, CJ Zheng, XJ Zhang, Z Liu, CS Lee, XH Zhang. “Non-blinking, highly luminescent, pH-and heavy-metal-ion-stable organic nanodots for bio-imaging” J. Mater. Chem. B 2013, 1 (25), 3144-3151.
64. J Zhang, F An, Y Li, C Zheng, Y Yang, X Zhang, X Zhang. “Simultaneous enhanced diagnosis and photodynamic therapy of photosensitizer-doped perylene nanoparticles via doping, fluorescence resonance energy transfer, and antenna effect”. Chem. Commun. 2013, 49 (73), 8072-8074.
65. Y Li, Y Yang, F An, Z Liu, X Zhang, X Zhang. “Carrier-free, functionalized pure drug nanorods as a novel cancer-targeted drug delivery platform” Nanotechnology 2013, 24 (1), 015103.
66. Y Yang, F An, Z Liu, X Zhang, M Zhou, W Li, X Hao, C Lee, X Zhang. “Ultrabright and ultrastable near-infrared dye nanoparticles for in vitro and in vivo bioimaging” Biomaterials 2012, 33 (31), 7803-7809.
67. W Li, Y Yang, C Wang, Z Liu, X Zhang, F An, X Diao, X Hao, X Zhang. “Carrier-free, functionalized drug nanoparticles for targeted drug delivery” Chem. Commun. 2012, 48 (65), 8120-8122.
68. X Diao, W Li, J Yu, X Wang, X Zhang, Y Yang, F An, Z Liu, X Zhang. “Carrier-free, water dispersible and highly luminescent dye nanoparticles for targeted cell imaging”. Nanoscale 2012, 4 (17), 5373-5377.
69. F An, X Zhang*, “Pure Photosensitizer Nanocrystals Stabilized with Amphiphilic Multidentate Polymer Ligands on the Surface for Ultra-high Payload and Enhanced Photodynamic Therapy.” 2012, “2nd Symposium on Innovative Polymers for Controlled Delivery”
已授权专利:
1. Richard Ting, Omer Aras, Feifei An, Nandi Chen. “One-step, fast, 18f-19f isotopic exchange radiolabeling of difluoro-dioxaborinins and use of such compounds in treatment” US12378261B2（2025.08.05授权，有效期至2042.05.01）， EP3796945A2 (2025.08.06授权，有效期至2039.05.23)。
2. Nai-Kong V. Cheung, Steven M. Larson, Sarah CHEAL, Richard Ting, Hari Krishna KOMMIDI, Feifei AN, Brian SANTICH. “Multimodal fluorine-cy3/5/7-dota-hapten compositions, diagnostics, fluorescence guided surgery and radioimmunotherapy”. US12533428B2（2026-01-27授权，有效期至2043-05-31）。
3. 张晓宏，安菲菲。 “一种基于白蛋白的疏水二氢卟吩光敏剂纳米药物制剂、制备方法及其应用.” （申请号／专利号：CN201310077732） 已授权。
4. 张晓宏, 张金凤, 安菲菲。 “具有荧光共振能量转移及天线效应的用于光动力治疗的光敏剂掺杂纳米粒子的制备方法”（申请号／专利号： CN201310131662）已授权。
5. 梁兴杰，张吉梅，安菲菲，李婵，李鸿基，王东亮，张旭，霍帅东，金叔宾，姜永刚。“一种双模式成像纳米胶束及其制备方法和用途”（专利号：CN201410350662）已授权。
6. 梁兴杰, 李鸿基, 安菲菲, 李婵, 张吉梅。“一种实现诊疗一体化的纳米胶束及其制备方法和应用” （专利号：CN201410437740）已授权。
7. 安菲菲,陈理查德,陈南迪。“波长可调的BODIPY纳米颗粒及制备方法和应用”（ 申请公布号：CN113967255A）已授权。
待授权专利：
8. Richard Ting，Omer Aras，Ye Wang，Kommiddi HARIKRISHNA，Hua Guo，Feifei AN，Nandi CHEN. “Fluorine-18 labeled compositions and their use in imaging of biological tissue” EP3781019A4
9. 安菲菲; 赵敏;胡硕;邓彩婷;周明;郑美辰;辛璟褀。“一种白蛋白吲哚菁绿复合物的放射标记物及其制备方法和应用”，CN115770303A
10. 安菲菲，张晶晶。“一种三叉状小分子药物偶联物及其制备方法”，CN120617534A
著作：
1. Feifei An, Jingjing Zhang, Omer Aras, Piflufolastat F-18, Illuccix, Posluma, Pluvicto, and beyond: the development of radiopharmaceuticals for prostate cancer theranostics, Drug Discovery Stories, Volume 2, Chapter 39: 565-581.
